NEPHROS INC NEPH
COM · Common Stock · CUSIP 640671400
- SectorHealth care
- IndustrySurgical & Medical Instruments & Apparatus
- HeadquartersSouth Orange, NJ
- FilingsSEC EDGAR
* Summed across managers. Shares that two managers' reports both contain – a subsidiary's holdings that its parent's report includes too, or a sub-adviser's in its client's – are counted once. Holder counts are more reliable. Shares outstanding: 10.5m as of 2023-08-07, from the company's own SEC filing; the percentage can still exceed 100%: lent-out shares are counted by the lender and the buyer, and some reports overlap without saying so. Implied quarter-end price ≈ $1.55.
Trends to Q2 2023
Institutional holders
Managers reporting a position, each quarter
Numbers
| Quarter | Holders |
|---|---|
| Q3 2022 | 19 |
| Q4 2022 | 20 |
| Q1 2023 | 19 |
| Q2 2023 | 17 |
Buyers vs sellers
Managers adding to or starting a position, vs cutting or selling out
Numbers
| Quarter | Bought or added | Cut or sold out |
|---|---|---|
| Q4 2022 | 6 | 6 |
| Q1 2023 | 2 | 9 |
| Q2 2023 | 4 | 7 |
Biggest buyers
| GEODE CAPITAL MANAGEMENT, LLC | Added | +66.2k |
| VANGUARD GROUP INC | Added | +17.6k |
| HighTower Advisors, LLC | Added | +1.0k |
| WELLS FARGO & COMPANY/MN | Added | +3 |
Biggest sellers
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Sold out | -36.0k |
| CITADEL ADVISORS LLC | Sold out | -15.3k |
| Tower Research Capital LLC (TRC) | Reduced | -10.9k |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | -9.5k |
| ELKHORN PARTNERS LIMITED PARTNERSHIP | Reduced | -5.0k |
| BARD ASSOCIATES INC | Reduced | -1.4k |
| UBS Group AG | Reduced | -226 |
Major shareholders (over 5%)
Anyone who owns more than 5% of a class of the company's shares has to say so: on Schedule 13D if they may try to influence or control the company, on 13G if they're a passive investor, and update it as the stake changes. Each holder's latest filing, from 19 Dec 2024 on; percentages are of the share class, as the holder worked them out.
| Holder | Stake |
|---|---|
| DAVIDSON CHARLES E 13G · passive investor new · filed 2026-09-16 | 5.7% |
| Topline Capital Management, LLC 13G · institution new · filed 2025-11-14 | 5.6% |
Fell to 5% or below in the last year: WEXFORD CAPITAL LP (2.1%, 2026-09-16)
Insider purchases and sales in Q2 2023
Shares bought or sold by the company's own officers, directors and 10% owners, in the open market or privately, as they reported to the SEC on Form 4 (due within two business days of the trade). Grants, option exercises, shares withheld for tax and gifts aren't included.
None reported in Q2 2023.
Holders, Q2 2023
| Manager | Shares | Change |
|---|---|---|
| WEXFORD CAPITAL LP 1.13% of their portfolio | 3.7m $5.7m | Unchanged |
| BARD ASSOCIATES INC 0.12% of their portfolio | 192.9k $299.1k | Reduced -1.4k |
| VANGUARD GROUP INC 0.00% of their portfolio | 164.3k $254.7k | Added +17.6k |
| GEODE CAPITAL MANAGEMENT, LLC 0.00% of their portfolio | 77.3k $119.9k | Added +66.2k |
| HighTower Advisors, LLC 0.00% of their portfolio | 56.7k $89.0k | Added +1.0k |
| ELKHORN PARTNERS LIMITED PARTNERSHIP 0.04% of their portfolio | 45.3k $70.0k | Reduced -5.0k |
| BLAIR WILLIAM & CO/IL 0.00% of their portfolio | 36.2k $56.2k | Unchanged |
| STATE STREET CORP 0.00% of their portfolio | 15.7k $24.3k | Unchanged |
| MORGAN STANLEY 0.00% of their portfolio | 15.3k $23.7k | Unchanged |
| RENAISSANCE TECHNOLOGIES LLC 0.00% of their portfolio | 13.7k $21.0k | Reduced -9.5k |
| BlackRock Inc. 0.00% of their portfolio | 4.1k $6.4k | Unchanged |
| Tower Research Capital LLC (TRC) 0.00% of their portfolio | 554 $859 | Reduced -10.9k |
| WELLS FARGO & COMPANY/MN 0.00% of their portfolio | 66 $102 | Added +3 |
| UBS Group AG 0.00% of their portfolio | 11 $17 | Reduced -226 |
| OSAIC HOLDINGS, INC. 0.00% of their portfolio | 5 $8 | Unchanged |
| ROYAL BANK OF CANADA 0.00% of their portfolio | 1 $0 | Unchanged |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0.00% of their portfolio | 0 $0 | Unchanged |